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INTRODUCTION 
EPIDEMIOLIOGY 
 38.6 million - HIV infection world over,  2.3 million, i.e. 5.9 % - 
children <15 years of age 
 In 2007- 5,40,000 children were born with HIV infection 
transmitted from their infected mothers      
 90% -  sub-saharan Africa & remaining in Asia , mainly in India 
 Estimated total no. of HIV infection in India :                    
o 3.97 million – 2001 
o 5.1   million – 2003 
o 5.134 million – 2004 
o 6.13 million - 2010 
 No.  Of children living with HIV in India – 0.17 million 
(UNAIDS report 2004) to 0.24 million(NACO estimate). 
 India – 3 zones  
 High prevalence  - HIV prevalence in ANC mothers > 1%  
 Medium prevalence - < 1% but in high risk population in STI 
clinics >20% 
 Low prevalence - <1% & in high risk < 20% 
  
2 
 
 High prevalence – (6) Maharashtra, Karnataka, Tamil Nadu, 
Andhra Pradesh, Manipur, Nagaland 
 Medium prevalence – (2) Gujarat, West Bengal 
 Low prevalence – rest of states 
 National average of HIV prevalence in Antenatal mothers – 
0.7% 
 Mother to child transmission- 15 to 30%- non-breastfeeding 
population, 30 to 45% - breastfeeding population. 
 
HIV VIRUS 
 Robert Galo. 1983. 
 RNA Virus 
 Retroviridiae, Lentivirus. 
 HIV-1,HIV-2 
 Three major groups - M,N,O 
 M (Major) – 9, subtypes – A,B,C,D,F,G,H,J,K 
 Subtype c (common). 
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MORPHOLOGY 
 GAG, POL, ENV 
 ENV-gp120, gp41. 
 POL-viral enzymes 
 GAG- P24, P17, P9, P6.  
HIV Virus 
Structure
 
HIV 1 
1. TAT, REV, NEF, VIF, VPR, VPU. 
2. Does not contain VPX.  
3. Commonest in India. 
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HIV 2 
 
1. Rare in India 
2. Common in African countries. 
3. Fewer immunological disturbances 
4. Low transmissibility 
5. Longer incubation period, Low efficiency CD4 binding. 
 
ROUTE OF TRANSMISSION 
 
 Mother to child transmission 
 Blood and blood products 
 Intravenous Drug users 
 Sexual transmission 
 
MOTHER TO CHILD TRANSMISSION 
 
 Commonest 
 Perinatal period is most vulnerable. 
 Factors influencing transmission 
1. High maternal viraemia  
2. Prolonged rupture of membranes 
3. STDs during pregnancy. 
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4. Preterm delivery. 
5. Obstetric procedures (episeotomy, aminocentesis). 
6. Vitamin A deficiency. 
RATE OF MOTHER TO CHILD TRANSMISSION 
 
Viral load Transmission rate 
<1000    cop/ml 0% 
1000-10000 16.6% 
10001-50000 21.3% 
50001-10000 30.9% 
>100000 40.6% 
 
 
CD4+ MOLECULE 
 55KDA protein responsible for helper or inducer function 
of immune system. 
 Also expressed on the surface of Monocytes /macrophages 
and Dendritic / Langerhan cells. 
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PATHOGENESIS  
CELL TYPES INFECTED  
 CD4 T cells 
 Dendritic cells 
 Monocytes/macrophages. 
 Microglial cells 
 Hofbauer cells  
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VIRAL REPLICATION IN CD4 CELL 
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PRIMARY HIV INFECTION 
 Mucosal dendritic cells bind gp120 with DC-SIGN. 
 Presents HIV to cells expressing CD4 molecule. 
 Transported to regional Lymph node. 
 Intense replication occurs in Lymph nodes. 
 Reaches critical level and burst of viraemia occurs. 
 Dissemination. 
 Occurs 3-6 weeks after infection. 
 Flu like illness – fever, arthralgia, rash lymphadenopathy. 
 CD8 T Cells  
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CHRONIC & PERSISTENT INFECTION 
Symptoms of acute viral disease disappear. 
 Drop in the detectable free and cell associated virus in the 
blood. 
 CD4 count almost normal level 
 All virologic parameters in the peripheral blood are very 
low. 
 Hallmark of HIV infection. Never eliminated completely. 
 Trapped viruses in FDCs activate CD4 cells 
 Lasts for 8-10 years in adult 
 
ADVANCED HIV DISEASE 
• Re emergence of free virus in both peripheral blood & lymph 
nodes. 
• Decline in CD4 & loss of function. 
• Emergence of faster replicating, more virulent strains. 
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• Loss of CD8 anti HIV activity. 
• Disruption of lymphnode architecture and loss of dendritic cell 
network. 
• Change of viral phenotype from NSI to SI. 
 
Mechanism of CD4 depletion and dysfunction 
• Direct damage by the virus. 
• Immune mechanism triggered. 
• Syncytium formation induced by virulent strains eliminates 
hundreds of uninfected cells. 
• Nonvirologic mechanism – autoimmune, anergy, super antigens, 
apoptosis. 
• Destruction of lymphocytes precursors. 
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0HIV IN CHILD DIFFERS FROM ADULT IN  
• Developing more severe bacterial infection. 
• Neuro-developmental problems. 
• Rapid progression of disease. 
• Higher mortality. 
• Opportunistic Infection as a primary disease rather than 
reactivation. 
 
PATTERN OF CLINICAL PROGRESSION 
• Rapid progressors  
• Slow progressors  
• Long term survivors  
RAPID PROGRESSORS 
• Considered infected in utero  
• Detectable virus within first 48 hours of life 
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• Symptomatic within first few months of life 
• Median survival – 6-9 months 
• Immuno competent cells will be infected before their migration 
to marrow, spleen, etc.  
• Establishment of infection before immune system develops. 
 
SLOW PROGRESSORS 
• Considered infected  intrapartum.  
• Detectable after first week of life. 
• Median survival - 6 years. 
• Failure to thrive / Recurrent bacterial infection. 
• Slow decline of viral load (due to immaturity of immune system)  
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LONG TERM SURVIVORS 
 
• Considered infected during breast feeding. 
• Manifest late in life (Considered as adult equivalents) 
• Minimal or no progression of the disease. 
• Relatively normal CD4 count and very low Viral load for longer 
than 8 years. 
• Remain alive >20 yrs. 
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WHO CLINICAL STAGING 
Primary HIV Infection 
• Asymptomatic  
• Acute retroviral syndrome 
Clinical Stage 1 
• Asymptomatic  
• Persistent generalized lymphadenopathy  
(enlarged lymphnode > 1cm at 2 or more non-contiguous sites) 
Clinical Stage 2 
 Unexplained persistent hepatosplenomegaly  
 Papular pruritic eruptions 
 Extensive wart virus infection  
 Extensive molluscum contagiosum  
 Recurrent oral ulcerations (2 or more in 6months) 
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 Unexplained persistent parotid enlargement. 
 Linear gingival erythema  
 Herpes zoster    
 Recurrent or chronic respiratory tract infections (otitis media, 
otorrhoea, sinusitis, tonsillitis) (>2episodes in 6months) 
Clinical Stage 3 
• Fungal nail infections  
• Moderate unexplained malnutrition, not adequately responding 
to standard therapy (>2SD below weight-for-age) 
• Unexplained persistent diarrhoea (14 days or more) 
• Unexplained persistent fever (>37.5 intermittent or constant, for 
longer than one month, with night sweats) 
• TB lymphadenitis 
• Pulmonary tuberculosis 
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• Persistent oral candida (outside first 6- 8 weeks of life) 
• Oral hairy leukoplakia  
• Acute necrotizing ulcerative gingivitis/periodontitis  
• Severe recurrent presumed bacterial pneumonia  
• Symptomatic lymphoid interstitial pneumonitis  
• Chronic HIV-associated lung disease including bronchiectasis  
• Unexplained anaemia (<8g/dl), neutropenia (<500/mm3) or 
chronic thrombocytopenia (<50 000/ mm3) 
Clinical Stage 4 
• Unexplained severe wasting, stunting or severe malnutrition not 
responding to standard therapy (>3SD below weight-for-age) 
• Pneumocystis pneumonia 
• Recurrent severe presumed bacterial infections  (e.g. empyema, 
pyomyositis, bone or joint infection, meningitis, but excluding 
pneumonia) 
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• Chronic herpes simplex infection; (orolabial or cutaneous of 
more than one month's duration or visceral at any site)  
• Extrapulmonary tuberculosis  
• Kaposi sarcoma 
• Oesophageal candidiasis (or candida of trachea, bronchi or 
lungs) 
• Central nervous system toxoplasmosis (outside the neonatal 
period) 
• HIV-associated cardiomyopathy or HIV-associated nephropathy  
HIV encephalopathy. 
• Cytomegalovirus (CMV) infection; retinitis or CMV infection 
affecting another organ, with onset at age over 1 month.          
• Extrapulmonary cryptococcosis including meningitis. 
• Disseminated endemic mycosis (extrapulmonary histoplasmosis, 
coccidiomycosis, penicilliosis) 
• Chronic Cryptosporidiosis  
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• Chronic Isosporiasis  
• Disseminated non-tuberculous mycobacteria infection.  
• Acquired HIV-associated rectal fistula.  
• Cerebral or B cell non-Hodgkin lymphoma. 
• Progressive  multifocal leukoencephalopathy. 
Clinical Signs Definitively - HIV Infection 
• Some clinical conditions are very unusual without HIV infection  
• Pneumocystis pneumonia 
• Oesophageal candidiasis  
• Lymphoid interstitial pneumonitis  
• Kaposi’s sarcoma 
• Cryptococcal meningitis 
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Diagnosis of these conditions thus suggests HIV infection  
• Need to perform an HIV antibody test  
DIAGNOSIS 
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DIAGNOSTIC TESTS 
 
 
Three Formats of HIV Rapid Tests 
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Advantages of Rapid Tests compared to ELISA 
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ANTIRETROVIRAL PROPHYLAXIS: MONOTHERAPY 
• Nevirapine (NACO Guidelines) 
o Mother – Single dose NVP 200mg onset of labour.  
o Baby - Syrup NVP 2mg/kg within 72 hours of delivery. 
• AZT (Not as per NACO Guidelines) 
 
o Mother   
 AZT from 14 weeks, Intrapartum (PACTG 076 )  
 AZT from 28 weeks, Intrapartum (PHPT 1 Thai Long) 
 AZT from 36 weeks, Intrapartum (PHPT 1 Thai Short) 
o Baby - Syrup AZT 2mg/kg qid for  6 weeks 
o Antiretroviral Therapy 
• Indicated for maternal health at clinical stage 3 & 4 
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• Mother 
o CD4 < 200 =AZT + 3TC + NVP  (start any time ) 
o CD4 250 to 350 = AZT + 3TC + EFV  (after first trimester) 
• Baby  
o Syrup AZT 2mg/kg qid for 4 weeks  
 
ANTI RETROVIRAL THERAPIES:  
 
Nucleoside/ Nucleotide transcriptase inhibitors (NRTIS) 
DRUGS     DOSAGE 
Abacavir      children >3 months to 18yrs: 
Ziagen, ABC 300 mg   8mg/kg PO bid 
Oral solution 20mg/ml 
  
Didanosine     120 mg/m^2 PO bid 
(Chewable buffered tablets, 
 Buffered Powder packets) 
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Emtricitabine    200 mg capsule PO once daily 
Emtriva, FTC capsules 
 
Stavudine     1 mg/kg PO bid 
Zent, d4T 
Non- Nucleoside/ Nucleotide transcriptase inhibitors (NNRTIS) 
DRUGS    DOSAGE 
Efavirenz 
Sustiva,EFV   Get once daily PO at bed time 
     Weight 10-15 kg 200mg 
         15- 20kg 250mg 
         20 - 25kg 300mg 
Nevirapine   <8 yrs - 4mg/kg PO once daily for 14 days 
Viramune, NVP  >8 yrs- 4mg/kg PO bid, if tolerated 
Tablet 200mg 
Suspension : 10mg/ml 
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PROTEASE INHIBITORS 
Amprenavir   4-16yrs and weighing <50kg 
Agenerase,APV   oral solution 22.5 mg/kg bid >50kg  
Liquid formulation :15mg/ml 1400mg/dose PO bid(max   
     2800mg/dose)  
Capsules: 50mg  
Atazanvir  not established 
Reyataz ATV 
Darunavir    limited data on paediatric dosing 
Lpinavir/ Ritonavir (co-formulated) 7-<15kg: 12mg LPV & 3mg 
RTV/kgPO 
Ritonavir     200mg/m fo every 12hrs 
Saquinvir     not established 
Tipranvir     limited data on safety 
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FUSION INHIBITORS 
Enfuvirtide     >6yrs 2mg/kg bid 
The Four Prong Model for Prevention of Mother to Child HIV 
Transmission: NACO 
    Prong 1  
 Primary Prevention of HIV Infection Among Women of 
Child Bearing Age and Young People.  
    Prong II  
 Prevention of Unintended Pregnancy Among HIV Infected 
Women  
    Prong III  
 Prevention of HIV Transmission from infected mother to her 
infant.  
    Prong IV  
 PPTCT Plus Provide Care and Support for HIV-infected 
Women and their Families 
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PPTCT FLOW CHART 
Positive mothers 
 
Counseled for MTP / mode of delivery / Infant feeding / STI / TB / 
Risk reduction Strategies 
  
Nevirapine prophylaxis to mother during  labour  
  
Neonate Monitoring  
  
Nevirapine to the new born (within 72 hrs)  
  
Follow up (PNC OPD, well baby clinic)  
  
HIV testing Baby 18 months 
  
Continuum, Care and Support (ART / OIs,       Diet / nutrition, 
referrals NGO / CBOs) 
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IMMUNISATION 
Recommendations for these vaccines differ from those for Immuno-
competent children: 
 BCG 
 Polio vaccine 
 Measles/MMR 
 Rotavirus vaccine 
 Varicella vaccine 
 
 MEASLES - The WHO recommends measles vaccine at 6 
months of age, followed by a second dose at 9 months of age.  
 
 MMR - The first dose at 1 Year of age. Second dose 1 month 
after the first dose rather waiting until age 4 to 6 years. 
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 PNEUMOCOCCAL VACCINE - Children <2 Yrs should be 
vaccinated according to the routine PCV schedule. 
 For incompletely vaccinated children aged 2-5 Yrs:  
1.  administer two doses of PCV at least 8 weeks apart. 
2. should also receive the 23-valent pneumococcal polysaccharide 
vaccine (PPV) ≥2 months after their last PCV dose with a single 
revaccination with the 23- valent vaccine 3–5 years later 
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REVIEW OF LITERATURE 
1. Sandeep B. Bavdekar, etal  
• This was a prospective study conducted between children age 18 
month and above admitted here tertiary care center in Mumbai, 
India, with a given clinical features  
• They were subjected to HIV testing using WHO UNAID 
strategy II  
• The Data obtained was analyzed using SPSS software programs. 
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RESULTS 
• 23 of the 115 (20%) children tested positive for HIV. 
• Sero positivity     - 83.3% - chronic dermatitis 
- 9.1% - chronic diarrhea                               
• Oral thrush, generalized dermatitis and generalized 
lymphadenopathy were the other significant factors predicting 
HIV seropositivity.   
• The probability of HIV infection was higher in children who had 
higher number of risk factors present concomitantly. 
CONCLUSION: 
 The probability of HIV infection in a child is dependent upon 
the  nature and number of manifestation present. 
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2.  Karande, etal - 
• This was a prospective study conducted children age 
group between 1 month to 12 years admitted at the 
department of paediatrics and microbiology LTMG 
Hospital Mumbai, India, with the given clinical features 
tested with ELISA. 
RESULTS 
• 24 Of the 204 children (110 male, 94 female) screened, 
were diagnosed as HIV   infected. 
• Seropositivity:   
40.6%  - oral candiasis. 
18.2%  - chronic diarrhea 
16.2%  - disseminated Tuberculosis 
14.4%  - severe malnutrition 
11.2%  - serious pyogenic infections 
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• Increase in number of risk factors increases the chance 
of the patient being HIV infected. 
CONCLUSION: Clinically directed screening does have a practical 
role in   diagnosing HIV infection in a poor resource setting. 
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3.Pol RR, etal 
 This study was conducted in proven HIV sero positive children 
aged between 1 1/2years to 12 years who are admitted between Apr 
2004 – June 2005 to pediatric ward KIMS ,Kubli with a given clinical 
features. 
RESULTS : 
• No of HIV sero positive patients admitted during the 
period of was 71  
• The major route of transmission was vertical transmission 
with a percentage of 94.37%  
  
38 
 
Common Symptom:  Common  opportunistic  infections 
 Persistent  Fever -70.42%      Tuberculosis              -38.03% 
 Persistent cough – 59.15%      Recurrent Diarrhoea -30.99% 
 Loss of appetite – 59.15%      Oral Candidiasis        -21.13% 
 Lymphadenopathy –57.75%       Recurrent Bacterial    
 Severe malnutrition -54.95%      Pneumonia                 -12.68% 
• Six children died during study period – 8.45% 
• which includes 4 cases of HIV – encephalopathy -5.63%  
 
CONCLUSION: 
 The major route of HIV infection was vertical transmission . 
Persistent fever, cough, loss of appetite and weight loss were common 
presenting clinical features. Tuberculosis was the commonest 
opportunistic  infection. 
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4.Shah. SR, etal – 
• This prospective study was conducted from Jan 2000 - Oct 
2001 at Mumbai’s territory care & referral teaching 
hospital, India. 
• Children aged between 1 month to 12 years were admitted 
and tested for HIV +ive by triple ELISA test, were enrolled 
in the study . 
• Status of  children more than 18 months of age was 
confirmed by DNA –PCR testing for HIV. 
RESULTS :  
• 50 positive children enrolled (31 male 19 female)  
• 42 were perinatally infected ,  
• 8 were infected via blood transfusion. 
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Clinical Features   
• PEM -90%       
• Fever for morethan 1 mth -50%   
• Weight loss for  more than1 mth -50%    
• Persistent generalized                
• Lymphadenopathy – 24%           
• Skin manifestations – 79 %           
• Patients died - 6 (mortality 14 %). 
Opportunistic infections noted 
Tuberculosis -19 cases  
Candidiasis – 6 cases  
  
41 
 
Pneumocystis Carinii  
Pneumonia – 4 cases  
Herpes zoster – 3 cases  
Giardiasis  - 1 case  
CONCLUSION: 
  The most common mode of acquiring HIV is perinatal 
transmission  in the pediatric age group. Most of the children who were 
tested +ive  have protein-energy malnutrition. The most common in 
HIV-infected Indian children was Tuberculosis. Patients with HIV-
encephalopathy have  less outcome. 
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5.Merchant RH et al – 
• This prospective study was conducted between July  
1994- 1996 in Wadia Children hospital  at Mumbai  
• 100 patients were enrolled out of that 50 children 
with disseminated TB and 50 with chronic diarrhea 
were tested for HIV sero positivity. 
• All  the children in the study were subjected to 
Elisa testing using the NOVOPATH  HIV1 and 11 
EIA kit of  Bio rad Labs. 
• The child was declared HIV seropositive only after 
confirming the test taken by using the 2 different 
Elisa methods for sero positive. 
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Disseminated TB  - 9 children  with a percentage of 18%  and for 
Chronic diarrhea -12 children with a percentage of 24%  were tested 
HIV seropositive ,  taking the total seropositivity to 21%. 
 
 The commonest mode of transmission 71% was pereinatal. The 
children with chronic diarrhea 40% had associated oral candiasis and 
some others  10% had both oral perianal candiasis. Out of the 21 
children who were HIV positive 6 children expired during the study 
period of 2 years with extensive Tubercluosis (3)and chronic 
diarrhea(3). 
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6.Mukadi et al –  
 This was  study of case-control and prospective nature.  The 
study period for this study was done during the month of  March 1994 
and November 1995. Children of age group from 0 till the age of 9 
years were considered.  The study was done in  diagnosed  two TB  
centers and  2 principal university hospitals in Abidjan, Cote d'Ivoire. 
Children were diagnosed serum samples were collected for HIV tests 
and lymphocyte phenotyping. X-ray of the chest  was taken.   Acid-fast 
bacilli smear and culture tests were done by taking the gastric aspirates 
and sputum samples.  Then followup were done for the children every 
2 months during a course of standard 6-months anti-TB therapy. To 
examine risk factors for TB, the siblings of children referred for TB 
skin testing on the basis of age and sex matched healthy control 
children.  
Results:   
• During this study a total of 161 children who have TB 
were enrolled which includes 39 children with  pulmonary 
TB which was culture confirmed that accounted to 24% , 
80 children had clinically diagnosed pulmonary TB, that  
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accounted to 50%, and  with extrapulmonary TB was 42 
children which accounted to 26%. Children with TB were 
significantly more likely than 161 control children to be 
HIV +ive (19 versus 0%), to have a past history of TB (55 
versus 16%) and to live in below poverty line status 
housing (24 versus 6%).  
• No prominent differences between HIV-sero+ive and 
sero-ive children were found in the distribution of 
radiologic abnormalities for pulmonary TB or in the site 
of extrapulmonary TB. 
•  The rate of mortality in children with HIV+ive was 
significantly more than in children with HIV-ive   
and with available lymphocyte subtyping results all deaths 
in HIV-seropositive children occurred in those  percentage 
of <10% CD4. 
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Conclusions: This study implies the HIV infection is the 
important significant  risk factor in the development of 
Tubercluosis in children. The mortality rate in this area due to 
HIV related immunosuppression is the major critical risk factor 
in this population. 
7.Chan, Siu Pun et al -  
 Atypical clinical manifestations and rapid progression of 
tuberculosis disease (TB) are well-recognized in adults with the 
acquired immunodeficiency syndrome (AIDS). There are few reports 
of children with AIDS and TB. We report the manifestations, clinical 
course and outcome of 12 pediatric patients with AIDS and TB. 
 The charts of all children admitted to our institution, from 1989 
through 1994, with the diagnoses of AIDS and culture-proved TB were 
reviewed. 
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Results: Twelve children between the ages of 2 months and 13 years 
fit the criteria. The mean time between the diagnosis of AIDS and TB 
was 20 months. The most frequent presenting symptoms were fever 
(75%) and tachypnea (33%). All had negative Mantoux tests  
(5 tuberculin units of purified protein derivative). Extrapulmonary TB 
was present in 3 (25%). A source case was identified for 4 (33%). 
Previous pulmonary disease was present in 7 (58%). Chest 
roentgenograms were abnormal in 11 (91%), with diffuse interstitial 
infiltration the most common finding. Susceptibility tests were 
performed on 10 strains, 3 of which were resistant to 1 or more 
antituberculosis drugs. Three patients (25%) died of TB, 1 of whom 
was appropriately treated with antituberculosis drugs but had a strain 
resistant to isoniazid and rifampin. 
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Conclusion: Children with AIDS and TB most frequently present with 
atypical manifestations of TB. A high index of suspicion is needed to 
correctly diagnose TB in this group of children. Early diagnosis is 
important because most respond well when treated appropriately. 
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STUDY JUSTIFICATION 
• HIV infection present with several manifestations none of them is 
specific; hence several children are subjected to HIV testing.  
• Few studies carried out to determine the likelihood of HIV infection 
with a given clinical features in Indian children.  
• If we know exactly the symptom / sign which are most predictive of 
HIV infection, we would be able to screen these children for the 
evidence optimally with out any over / under estimation. 
• Ours being one of the premier institute in south east Asia catering 
the health care of children, the study could be helpful in providing 
clinical features for early diagnosis /reference /and follow-up.  
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AIM OF THE STUDY 
 
To determine the probability of HIV infection when a child is 
presenting with,  
 
a)  One of the selected clinical features and 
b)  in combinations. 
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SUBJECTS AND METHODS 
 
1.  METHODOLOGY 
STUDY DESIGN 
 Descriptive study 
 
STUDY PLACE 
 In patients and out patients department, ICH. 
 
STUDY  PERIOD 
 Jun 2011 to oct 2012. 
STUDY POPULATION 
 Cases with the given  clinical features attended in out patient 
department and admitted in Inpatient department of ICH and HC, 
Egmore, Chennai. 
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CASE DEFINITION    
 
Recurrent Pneumonia 
 Cough with tacypnea, (respiratory rate 50 or more in children 
aged 1yr to 5yrs and 25 or more in 6 to 12yrs with radiological 
clearance in between 2 episodes of pneumonia).  
Persistent diarrhea 
 2 or 3 loose stools per day for more than 14 days 
Ear Discharge 
 Ear pain or ear discharge from patient history or visible pus 
draining from ear or tender swelling behind ear.  If reported less than 
14 days is acute and if more than 14days, its chronic.  
Very low weight or Severe malnutrition 
  Grade II, III & IV malnutrition (as per weight for age)  
Oral thrush 
 White patches in mouth which can be scraped off or red patches 
on tongue, palate, or lining of mouth, usually painful or tender. 
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Parotid enlargement  
Asymptomatic bilateral parotid swelling of unknown cause, 
usually painless. 
Generalized Lympadenopathy 
  Enlarged lymph nodes more than 1cm at 2 or more non 
contiguous sites of unknown cause. 
Chronic or refractory skin or mouth conditions 
  If chronic (lasting for more than 3 months) or a re refactory (do 
not respond to standard therapy), they include: Papular itching rash, 
ring worm, scabies, impetigo, seborrhea, gum and mouth ulcers. 
Disseminated TB 
 Millary, CNS, Pulmonary Tuberculosis 
Hepatomegaly  
 Enlarged liver (liver span more than that of normal for that 
age)(no obvious cause). 
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Encephalopathy 
 Generalized disorder of cerebral function (no obvious cause)  
Fever for more than one month  
 unexplained fever for more than one month. 
Inclusion criteria 
  Children between the age group of 18 months to 12 years who 
met the case definition for HIV. 
Sample size:       All suspected children with the age group between 18 
months to 12 years were enrolled. 
MANOEUVRE 
 All children satisfied the inclusion criteria during the period of 
study was recruited. 
 Demographic data, history and examination findings and test results 
were recorded in a  pre designed proforma.
 
 
 Blood sample from suspected cases will be collected and sent to 
ICTC, ICH for screening of HIV. 
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 Test for HIV : Rapid screening test - 
   (i)  Immunodot assay 
   (ii) Immuno Chromato graphic based assay 
   (iii)Immuno Concentration based assay 
1. STATISTICAL ANALYSIS:  
 The proportion of various clinical features among seropositive 
and seronegative for HIV were compared using chi-square test. The 
association of clinical features to seropositivity was measured also by 
multivariant analysis of arriving at Odds Ratio with 95% confidence 
interval OR (95% CI) and adjustable OR (95% CI). P<0.05 was 
consider for statistical significance. The trend of association between 
number of clinical features with proportion of seropositivity was 
analysed with chi-square test for trend. 
2. ETHICS 
Patient consent and IRB approval obtained. 
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OBSERVATIONS 
Total cases screened    :  1647 
Number of cases with HIV positivity  :    24 
 Totally 1647 children were screened, from June 2011 to October 
2012 with the age group between 18 months and 12 years were 
enrolled in this study. Out of whom 991 (60%) children were males 
and 656 (40%) were females.  
 
Fig.1.Comparison of sex distribution among HIV positive and negative 
children 
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 Among these 1647 children, 24 were HIV positive out of whom 
11 (46%) children were male and 13 (54%) children were female with 
male to female. 
  
 
Fig. 2.Comparision of age distribution of HIV positive cases 
Among the 24 HIV positive  children,   10 (42%) children were 
between the age group 18 months to 5yrs and 14 (58%) children were 
between the group 5yrs to 12 yrs. 
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Occupational status of parents of HIV positive children 
 
Fig.3.Occupational status of parents of HIV positive children 
 Among 24 HIV positive children the occupational status of their 
parents was analysed. Most of the mothers, that is 18(75%)of them 
were labourers and 6(25%) were skilled labourers. Same was in the 
case of fathers, 19(79%)were labourers and 5(21%) were skilled 
labourers.  
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Table - 1 
Clinical Features in relation to Serological Status for HIV 
Infection 
Clinical Manifestations   HIV sero 
(+ive) 
HIV 
sero  
(-ive) 
P-Value 
Recurrent Pneumonia  4 
(16.7%) 
43  
(2.6%) 
0.004 
Persistent diarrhea 3 
(12.5%) 
21 
(1.3%) 
0.005 
Chronic Ear discharge 1 
(4.2%) 
2 
(0.1%) 
0.043 
Very low weight or severe 
malnutrition 
3 
(12.5%) 
15 
(0.9%) 
0.002 
Oral thrush  0 
(0.0%) 
11 
(1.5%) 
0.850 
Bilateral Parotid enlargement  0 
(0.0%) 
2 
(0.1%) 
0.971 
Generalized lymphadenopathy 1 
(4.2%) 
15 
(0.9%) 
0.210 
Chronic or  refractory skin or mouth 
conditions  
2 
(8.3%) 
15 
(0.9%) 
0.024 
Disseminated TB  2 
(8.3%) 
9 
(0.6%) 
0.010 
Hepatomegaly (No obvious cause ) 1 
(4.2%) 
5 
(0.3%) 
0.084 
Encephalopathy(No obvious cause ) 1 
(4.2%) 
6 
(0.4%) 
0.098 
Fever more than 1 month 6 
(25.0%) 
77 
(4.7%) 
0.001 
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Fig.4.Comparison of Sero positivity and Negativity of HIV Positive 
children 
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Table - 2 
Clinical features in relation to Univariate analysis 
Clinical manifestations   Odds Ratio 95% C.I.  
Recurrent Pneumonia  7.35 2.41 – 22.42 
Persistent diarrhea 10.90 3.02 – 39.35 
Chronic Ear discharge 35.24 3.08 – 402.5 
Very low weight or severe 
malnutrition 
15.31 4.12 – 56.88 
Oral thrush  - - 
Bilateral  parotid enlargement  - - 
Generalized Lymphadenopathy 4.66 0.59 – 36.78 
Chronic or  refractory skin or mouth 
conditions  
9.74 2.10 – 45.20 
Disseminated TB  16.30 3.33 – 79.9 
Hepatomegaly (No obvious cause ) 14.07 1.58 – 125.2 
Encephalopathy (No obvious cause ) 11.72 1.36 – 101.3 
Fever for more than one month 6.69 2.58 – 17.34 
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Recurrent pneumonia was observed among 4 cases out of  
24 cases  who were serologically positive for HIV when compared to 
43 (2.6%) among 1623 sero negatives (P:0.004), Odds of having 
Recurrent Pneumonia was 7 times more among seropositives when 
compared to seronegatives [OR with 95% CI = 7.(35 2.41 – 22.42)]. 
 
Three children (12.5%) among HIV positives had persistant 
diarrhea when compared to 1.3% among who were tested negative for 
HIV serology. Possibility of a child with  chronic diarrhea among HIV 
positives is 10 times more likely when compared to those who were 
seronegatives. [OR with 95% CI = 10.9 (3.02 – 39.35)]. 
 
One child (4.2%) among HIV positives had chronic ear 
discharge when compared to 0.1% among who were tested negative for 
HIV serology. Possibility of child having chronic ear discharge among 
HIV positive is 35 times more likely when compared to those who 
were seronegative [OR with 95% CI = 35.24 (3.08 – 402.5)]. 
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Three children (12.5%) among HIV positives had very low 
weight when compared to 0.9% among who were tested negative for 
HIV serology. Possibility of child having very low weight among HIV 
positive to 15.31 times more likely when compared to those who were 
seronegative.[OR with 95% CI = 15.31 (4.12 – 56.88)]. 
 
  11 (1.5%) children with oral thrush were negative for HIV 
serology. No children with oral thrush found to be HIV positive. P-
value was 0.850. 
 
Two (0.1%) children with Bilateral parotid enlargement were 
negative for HIV serology. No children with Bilateral parotid 
enlargement found to be HIV positive P-value was 0.971. 
 
One child (4.2%) among HIV positives had generalized lymph 
adenopathy when compared to 15 (0.9%) who were tested negative for 
HIV serology. Possibility of a child having generalized lymph 
adenopathy among HIV positives is 4 times more likely when 
compared to those who are  seronegatives [OR with 95% CI = 4.66 
(0.59 – 36.78)]. 
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Two children (8.3%) among HIV positives had chronic 
refractory skin infection when compared to 15 (0.9%) among who 
were tested negative for HIV serology. Possibility of a child having 
Chronic refractory skin infection among HIV positives is 9 times more 
likely when compared to those who were seronegatives [OR with 95% 
CI = 9.74 (2.10 – 45.20)]. 
 
Two children (8.3%) among HIV positives had disseminated TB 
when compared to 9 (0.9%) among who were tested negative for HIV 
serology. Possibility of a child having disseminated TB among HIV 
positives is 16 times more likely when compared to those who were 
seronagatives [OR with 95% CI = 16.30 (3.33 – 79.97)]. 
 
One child (4.2%) among HIV positive had hepatomegaly (no 
obvious cause) when compared to 5 (0.3%) among who were tested 
negatives for HIV serology. Possibility of a children having 
hepatomegaly (no obvious cause) among HIV positive was 14 times 
more likely when compared to those who were seronegatives OR with 
95% CI = [14.07 (1.58 – 125.2)] 
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One child (4.2%) among HIV positives had encephalopathy (no 
obvious cause). When compared to 6 (0.4%) among who were tested 
negative for HIV serology. Possibility of a child having 
encephalopathy (no obvious cause) among HIV positives  is  11.72 
times more likely when compared to those who are  seronegative  
[OR with 95% CI = 11.72 (1.36 – 101.3)]. 
 
Six children (25.0%) among HIV positives had fever more than 
one month when compared to 77 (25.0%) among who were tested 
negative for HIV serology. Possibility of a children with  fever more 
than one month among HIV positives is 6.69 times more likely when 
compared to those who are seronegative [OR with 95% CI = 6.69  
(2.58 – 17.34)]. 
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Table - 3  
HIV seropositivity in relation to the number of clinical 
features present 
 
No. of clinical 
features 
HIV positive  
cases 
HIV negative 
cases 
P-value 
1 4 
(5.0%) 
76  
(95.0%) 
0.003 
2 10  
(9.1%) 
100  
(90.9%) 
3 6  
(13.3%) 
39  
(86.7%) 
4 4  
(40.0%) 
6  
(60.0%) 
 
 When there was a single clinical features predicting HIV 
positivity was 5% when compare to 40% among those who had  
4 clinical features. There was steady increasing trend of seropositivity 
from one feature to four features which was found to be statistically 
significant (P = 0.003). 
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DISCUSSION 
 Human immunodeficiency virus(HIV) is estimated to be 
constituted by 3 to 5% by paediatric age group less than 15 years 
amondg all  cass reported.  The registered paediatric cases at various 
institutions are far below the estimated.  
 38.6 million - HIV infection world over,  2.3 million, i.e. 5.9 % - 
children <15 years of age. In 2007- 5,40,000 children were born with 
HIV infection transmitted from their infected mothers. 90% -  sub-
saharan Africa & remaining in Asia , mainly in India Estimated total 
no. of HIV infection in India 3.97 million – 2001,5.1   million – 2003, 
5.134 million – 2004, 6.13 million – 2010, No.  Of children living with 
HIV in India – 0.17 million (UNAIDS report 2004) to 0.24 million 
(NACO estimate). 
 In India, it is divided into  3 zones.  High prevalence  - HIV 
prevalence in ANC mothers > 1%.  Medium prevalence - < 1% but in 
high risk population in STI clinics >20%. Low prevalence - <1% & in 
high risk < 20% High prevalence – (6) Maharashtra, Karnataka, 
Tamilnadu, Andhrapradesh, Manipur, Nagaland. Medium prevalence – 
(2) Gujarat, West Bengal Low prevalence – rest of states. National 
average of HIV prevalence in AN mothers – 0.7%  MTCT- 15 to 30%- 
non-breastfeeding population, 30 to 45% - breastfeeding population. 
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 We suspect HIV infection when a child presents with the given 
clinical feature either in single or combined like recurrent pneumonia, 
persistent diarrhea, ear discharge, very low weight or severe 
malnutrition, oral thrush, parotid enlargement, generalized 
lympadenopathy, chronic refractory or mouth conditions, disseminated 
TB, hepatomegaly, encephalopathy, fever for more than one month. 
 
 There is a possibility of other conditions with these symptoms or 
signs, with this background review of literature was done. 
 
 In our study we found 24 children were diagnosed as HIV 
infection positive. Out of them in our study, seropositivity for recurrent  
pneumonia  (16.7%), persistent diarrhea(12.5%), ear discharge (4.2%), 
oral thrush(0%), very low weight or severe malnutrition(13.6%), 
parotid enlargement(0%), generalized lympadenopathy(4.2%), chronic 
refractory or mouth conditions(8.3%), disseminated TB(8.3%), 
hepatomegaly(4.2%), encephalopathy(4.2%), fever for more than one 
month(25%). 
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 Karande, etal conducted study between 1 year to 12 years 
admitted at the department of pediatrics and microbiology LTMG 
Hospital Mumbai. Out of 204 children screened 24 were diagnosed as 
HIV infected. The sero positivity was 40.6% for oral candiasis, 18.2% 
for chronic diarrhea, 16.2%for disseminated TB, 14.4% for severe 
malnutrition, 11.2% for serious pyogenic infections. This study 
concluded that clinically directed screening does have a practical role 
in diagnosing HIV infection in a poor resource setting. The diagnostic 
test was done by Elisa. 
 
 In our study, we included the age group between 18 months and 
12 years of age, out of 1647 children screened 24 were diagnosed as 
HIV infected. In our study the seropositivity of clinical features 
compared to Karande, et al study were for recurrent pneumonia 
(16.3%), persistent diarrhea(12.5%), ear discharge (4.2%), oral 
thrush(0%), very low weight or severe malnutrition(12.5%), parotid 
enlargement(0%), generalized lympadenopathy(4.2%), chronic 
refractory or mouth conditions(8.3%), disseminated TB(8.3%), 
hepatomegaly(4.2%), encephalopathy(4.2%), fever for more than one 
month(25%).  The diagnostic test was done by rapid screening test no 
children with oral thrush was found to be seropositive compared to 
Karande, etal study. 
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 Pol  RR, etal  study was conducted in proven HIV sero positive 
children aged between 18 months to 12 years admitted between Apr 
2004 to June 2005 in pediatric medical ward KIMS, Kubli with the 
given clinical features. The seropositivity for persistent fever was 
70.42%, persistent cough 59.15%, loss of appetite 59.15%, 
lymphadenopathy 57.75%, severe malnutrition 54.95%, tuberculosis 
38.03%, recurrent diarrhea 30.99%, oral candidiasis 21.13%, recurrent 
bacterial pneumonia 12.68%. Six children died during study period 
8.45% which includes 4 cases of encephalopathy 5.63%.  Vertical 
transmission was the major route of HIV infection. Persistent fever, 
cough, loss of appetite and loss of weight were common presenting 
clinical features.  Tuberculosis was the commonest opportunistic 
infection. 
 
In our study seropositive for fever more than one month was 
25.0% when compared to Pol  RR, etal  study it was 70.42%. In our 
study the following clinical features emerged a independent predictors 
of HIV infection were fever more than one month, Very low weight or 
severe malnutrition, Recurrent pneumonia, Persistent diarrhea which 
were compared similar to Pol  RR, etal  study. 
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Merchant RH etal- In his study 18% seropositive for 
Disseminated TB  and 24% for chronic diarrhea. In our study 
Disseminated TB 8.3% and 12.5% for chronic diarrhea. In his study 
children were subjected to Elisa, in our study children were subjected 
to Rapid screening test. 
 
 
Sandeep B. Bavdekar, etal- In his study 83.3% seropositive for 
chronic dermatitis compared to our study was 8.3%. In his study 
showed oral thrush was significant risk factor compare to our study we 
did not find that oral thrush was as a significant clinical feature for 
HIV sero status. 
  
72 
 
 
 
In our study severe malnutrition was 12.5% compared to 90% 
PEM in Shah. SR, etal- study and also found that skin manifestations 
of his study were 79% compared to our study was 8.3%. 
 
 
Recurrent Bacterial Pneumonia was 16.7% sero positive and 
Generalized lymphadenopathy was 4.2% in our study compared to Pol 
RR, etal- study Recurrent Bacterial Pneumonia was 12.68% sero 
positive and Generalized lymphadenopathy was 57.75%. 
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CONCLUSION 
 Clinical profile of HIV in our study correlates with other 
literature. 
 In our study, the following clinical features emerged a 
independent predictors of HIV infection. 
1. Fever more than one month 
2. Very low weight or severe malnutrition 
3. Recurrent pneumonia 
4. Persistent diarrhea 
 Other important clinical features were chronic Ear discharge, 
disseminated TB, Hepatomegaly, recurrent skin infections. 
 There was an increasing trend in  rate of sero positivity with 
single to more number of these clinical features. 
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LIMITATION 
 
 Our study has  its share of limitations also as we did not 
included children below 18 months  as diagnosing HIV infection in 
them would have entailed performance of HIV DNA PCR. This  was 
not possible due to financial constraints. 
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RECOMMENDATION 
 
 If a child presenting with the above clinical features in single or 
in combination should be suspected to have HIV infection and 
investigated  accordingly. This will avoid ordering HIV Testing 
in un warranted situations. 
 
 From this if we know exactly the symptoms / signs which are 
most predictive of HIV infection, we would be able to screen 
these children for the evidence optimally with out any over / 
under estimation. 
 
 
 
